Analysis of the Quality of Life, the Clinical Effectiveness and Cost-effectiveness of a Novel Educational Programme in Patients With Psoriasis and Atopic Dermatitis
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital, Ghent
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients who have given written informed consent
Women or men of any race
Patients who are 18-75 years of age
Diagnosis of psoriasis or atopic dermatitis
You may not be if
Patients with a cognitive disorder (not able to understand, speak, read or write..)
Patients with a significant underlying medical cause (i.e. severe infection, haematologic disease, malignity, severe renal or hepatic disease, major depression) in the last 3 months
Patients under experimental pharmaceutical medication
Clareo Health | Analysis of the Quality of Life, the Clinical Effectiveness and Cost-effectiveness of a Novel Educational Programme in Patients With Psoriasis and Atopic Dermatitis